Thomas Sciascia - Net Worth and Insider Trading
Thomas Sciascia Net Worth
The estimated net worth of Thomas Sciascia is at least $4 Million dollars as of 2026-08-10. Thomas Sciascia is the Chief Scientific Officer of Trevi Therapeutics Inc and owns about 221,373 shares of Trevi Therapeutics Inc (TRVI) stock worth over $4 Million. Details can be seen in Thomas Sciascia's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Sciascia has not made any transactions after 2025-03-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Sciascia
Thomas Sciascia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Sciascia owns 1 companies in total, including Trevi Therapeutics Inc (TRVI) .
Click here to see the complete history of Thomas Sciascia’s form 4 insider trades.
Insider Ownership Summary of Thomas Sciascia
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| TRVI | Trevi Therapeutics Inc | 2025-03-25 | 10 percent owner & Chief Medical Officer |
Thomas Sciascia Latest Holdings Summary
Thomas Sciascia currently owns a total of 1 stock. Thomas Sciascia owns 221,373 shares of Trevi Therapeutics Inc (TRVI) as of March 25, 2025, with a value of $4 Million.
Latest Holdings of Thomas Sciascia
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics Inc | 2025-03-25 | 221,373 | 18.49 | 4,093,187 |
Holding Weightings of Thomas Sciascia
Thomas Sciascia Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Sciascia has made a total of 4 transactions in Trevi Therapeutics Inc (TRVI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Trevi Therapeutics Inc is the sale of 2,631 shares on March 25, 2025, which brought Thomas Sciascia around $17,365.
Insider Trading History of Thomas Sciascia
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Thomas Sciascia Trading Performance
Thomas Sciascia Ownership Network
Ownership Network List of Thomas Sciascia
Ownership Network Relation of Thomas Sciascia
Thomas Sciascia Owned Company Details
What does Trevi Therapeutics Inc do?
Who are the key executives at Trevi Therapeutics Inc?
Thomas Sciascia is the 10 percent owner & Chief Medical Officer of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include Chief Financial Officer David C Hastings , director & 10 percent owner & See Remarks Jennifer L Good , and Chief Commercial Officer Farrell Simon .
Trevi Therapeutics Inc (TRVI) Insider Trades Summary
Over the past 18 months, Thomas Sciascia made 1 insider transaction in Trevi Therapeutics Inc (TRVI) with a net sale of 2,631. Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 81,313 shares made by Farrell Simon , a net sale of 5,263 shares made by Jennifer L Good ,
In summary, during the past 3 months, insiders sold 0 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 89,207 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 89,207 shares.
Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Trevi Therapeutics Inc Insider Transactions
Thomas Sciascia Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Sciascia. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Thomas Sciascia's mailing address is: Danbury Ct 06810.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
